224 related articles for article (PubMed ID: 15826603)
1. Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant.
Leveau P; Wang X; Sun Z; Börjesson A; Andersson E; Andersson R
Biochem Pharmacol; 2005 May; 69(9):1325-31. PubMed ID: 15826603
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of platelet-activating factor, intercellular adhesion molecule 1 and platelet endothelial cell adhesion molecule 1 reduces experimental pancreatitis-associated gut endothelial barrier dysfunction.
Wang X; Sun Z; Börjesson A; Andersson R
Br J Surg; 1999 Mar; 86(3):411-6. PubMed ID: 10201790
[TBL] [Abstract][Full Text] [Related]
3. Effect of a platelet-activating factor antagonist on pancreatitis-associated gut barrier dysfunction in rats.
Andersson R; Wang X; Sun Z; Deng X; Soltesz V; Ihse I
Pancreas; 1998 Aug; 17(2):107-19. PubMed ID: 9700940
[TBL] [Abstract][Full Text] [Related]
4. Treatment with lexipafant ameliorates the severity of pancreatic microvascular endothelial barrier dysfunction in rats with acute hemorrhagic pancreatitis.
Wang X; Sun Z; Börjesson A; Haraldsen P; Aldman M; Deng X; Leveau P; Andersson R
Int J Pancreatol; 1999 Feb; 25(1):45-52. PubMed ID: 10211421
[TBL] [Abstract][Full Text] [Related]
5. Effective treatment of gut barrier dysfunction using an antioxidant, a PAF inhibitor, and monoclonal antibodies against the adhesion molecule PECAM-1.
Sun Z; Olanders K; Lasson A; Dib M; Annborn M; Andersson K; Wang X; Andersson R
J Surg Res; 2002 Jun; 105(2):220-33. PubMed ID: 12121711
[TBL] [Abstract][Full Text] [Related]
6. Roles of platelet-activating factor, interleukin-1beta and interleukin-6 in intestinal barrier dysfunction induced by mesenteric arterial ischemia and reperfusion.
Sun Z; Wang X; Lasson A; Börjesson A; Leveau P; Haraldsen P; Andersson R
J Surg Res; 1999 Nov; 87(1):90-100. PubMed ID: 10527709
[TBL] [Abstract][Full Text] [Related]
7. Platelet activating factor antagonism reduces the systemic inflammatory response in a murine model of acute pancreatitis.
Lane JS; Todd KE; Gloor B; Chandler CF; Kau AW; Ashley SW; Reber HA; McFadden DW
J Surg Res; 2001 Aug; 99(2):365-70. PubMed ID: 11469912
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of lexipafant, a PAF antagonist on gut barrier dysfunction caused by intestinal ischemia and reperfusion in rats.
Sun Z; Wang X; Deng X; Lasson A; Soltesz V; Börjesson A; Andersson R
Dig Surg; 2000; 17(1):57-65. PubMed ID: 10720833
[TBL] [Abstract][Full Text] [Related]
9. Effects of inhibition of PAF, ICAM-1 and PECAM-1 on gut barrier failure caused by intestinal ischemia and reperfusion.
Sun Z; Wang X; Lasson A; Böjesson A; Annborn M; Andersson R
Scand J Gastroenterol; 2001 Jan; 36(1):55-65. PubMed ID: 11218240
[TBL] [Abstract][Full Text] [Related]
10. Multimodal management - of value in fulminant acute pancreatitis?
Haraldsen P; Sun ZW; Börjesson A; Olanders K; Lasson A; Andersson R
Pancreatology; 2003; 3(1):14-25. PubMed ID: 12649560
[TBL] [Abstract][Full Text] [Related]
11. Role of mast cells in the development of pancreatitis-induced multiple organ dysfunction.
Dib M; Zhao X; Wang XD; Andersson R
Br J Surg; 2002 Feb; 89(2):172-8. PubMed ID: 11856129
[TBL] [Abstract][Full Text] [Related]
12. Early treatment with lexipafant, a platelet-activating factor-receptor antagonist, is not sufficient to prevent pulmonary endothelial damage after intestinal ischaemia and reperfusion in rats.
Börjesson A; Wang X; Sun Z; Inghammar M; Truedsson L; Andersson R
Dig Liver Dis; 2002 Mar; 34(3):190-6. PubMed ID: 11990391
[TBL] [Abstract][Full Text] [Related]
13. Effects of platelet activating factor antagonist (BN50739) on gut mucosal injury in acute severe pancreatitis in pigs.
Zhu W; Li J; Tu W; Li N
Chin Med J (Engl); 2000 Aug; 113(8):756-8. PubMed ID: 11776064
[TBL] [Abstract][Full Text] [Related]
14. Lexipafant and acute pancreatitis: a critical appraisal of the clinical trials.
Abu-Zidan FM; Windsor JA
Eur J Surg; 2002; 168(4):215-9. PubMed ID: 12440758
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of vascular endothelial growth factor on intestinal epithelial apoptosis and bacterial translocation in experimental severe acute pancreatitis.
Nakajima T; Ueda T; Takeyama Y; Yasuda T; Shinzeki M; Sawa H; Kuroda Y
Pancreas; 2007 May; 34(4):410-6. PubMed ID: 17446839
[TBL] [Abstract][Full Text] [Related]
16. Effect of platelet-activating factor antagonist WEB 2086 on microcirculatory disorders in acute experimental pancreatitis of graded severity.
Mann O; Tiefenbacher WJ; Kaifi J; Schneider C; Kluth D; Bloechle C; Yekebas E; Izbicki JR; Strate T
Pancreas; 2009 Jan; 38(1):58-64. PubMed ID: 18695628
[TBL] [Abstract][Full Text] [Related]
17. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis.
Johnson CD; Kingsnorth AN; Imrie CW; McMahon MJ; Neoptolemos JP; McKay C; Toh SK; Skaife P; Leeder PC; Wilson P; Larvin M; Curtis LD
Gut; 2001 Jan; 48(1):62-9. PubMed ID: 11115824
[TBL] [Abstract][Full Text] [Related]
18. Role of enteral nutrition supplemented with ebselen and EHEC in pancreatitis-associated multiple organ dysfunction in rats.
Zhao H; Lu HG; Shi YB; Zhao LM; Bai C; Wang X
Inflamm Res; 2006 Oct; 55(10):423-9. PubMed ID: 17109069
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of N-acetyl-L-cysteine and platelet activating factor inhibition are not linked to intercellular adhesion molecule-1 expression after intestinal ischemia and reperfusion injury in rats.
Olanders K; Börjesson A; Sun ZW; Andersson R
Scand J Gastroenterol; 2003 Jun; 38(6):618-25. PubMed ID: 12825870
[TBL] [Abstract][Full Text] [Related]
20. Role of high-mobility group box 1 protein in the pathogenesis of intestinal barrier injury in rats with severe acute pancreatitis.
Luan ZG; Zhang H; Ma XC; Zhang C; Guo RX
Pancreas; 2010 Mar; 39(2):216-23. PubMed ID: 19786932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
